![Gregory Ho](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Ho
Fondateur chez
HiPoint Capital LP
Profil
Mr. Ho is the President of SMC and one of its founding partners, as well as the head of the Opportunity Zones Group.
Prior to joining SMC in 2001, Mr. Ho was a Principal and Chief Financial Officer of McKinsey.
During his 16 years with McKinsey, he led the financial and tax planning for the firm and its worldwide partner group.
Mr. Ho also was a member of the firm’s Investment Committee and a Trustee of McKinsey’s Profit-Sharing Retirement Plan (PSRP).
In these capacities, he oversaw the identification, evaluation, and selection of traditional and alternative asset managers and investments for over $1 billion of assets managed by the McKinsey Investment Office (MIO).
After leaving McKinsey in 1998 and prior to joining SMC, Mr. Ho was a private investor and consultant.
Prior to joining McKinsey, he was associated with the law firm of Donovan Leisure Newton & Irvine.
Mr. Ho is a currently a member of the Advisory Board of Venture for America and the Advisory Council for Columbia Law School’s Center for Public Research and Leadership.
He received a J.D.
from Columbia Law School and a B.S., with honors, in Administrative Science from Yale College.
He is a member of the New York Bar and the California Bar.
Postes actifs de Gregory Ho
| Sociétés | Poste | Début |
|---|---|---|
Spring Mountain Capital LP /Private Equity/
 Spring Mountain Capital LP /Private Equity/ Investment ManagersFinance Spring Mountain Capital invests in companies located in the United States with revenues of USD 2-20 million. The firm focuses on health and technology sectors such as enterprise software, technology-enabled services, digital health and healthcare services. It participates in growth transactions with an investment size of USD 5 – 15 million. The firm acquires minority interest and takes a seat on the board of directors. | President | 01/07/2001 |
HiPoint Capital LP | Fondateur | 10/06/2011 |
Renetx Bio, Inc.
 Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | Directeur/Membre du Conseil | - |
Museum of Chinese in America
 Museum of Chinese in America Other Consumer ServicesConsumer Services Operates museum | Directeur/Membre du Conseil | - |
Atlasxomics, Inc.
 Atlasxomics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Président | - |
New York State Bar Association
 New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Corporate Officer/Principal | - |
Allyx Therapeutics, Inc.
 Allyx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops therapies to protect synapses from destruction in Alzheimer's and related neurodegenerative diseases | Directeur/Membre du Conseil | - |
Venture For America, Inc.
 Venture For America, Inc. Personnel ServicesCommercial Services Provides recruitment and training services | Corporate Officer/Principal | - |
Anciens postes connus de Gregory Ho
| Sociétés | Poste | Fin |
|---|---|---|
| ISOPLEXIS CORPORATION | Directeur/Membre du Conseil | 21/03/2023 |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Gregory Ho
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Donovan Leisure Newton & Irvine | Commercial Services |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | Health Technology |
IsoPlexis Corp.
 IsoPlexis Corp. Medical SpecialtiesHealth Technology Develops single cell multiplexing immunoassay systems | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Commercial Services |
California State Bar Association | |
Spring Mountain Capital LP /Private Equity/
Spring Mountain Capital LP /Private Equity/ Investment ManagersFinance Spring Mountain Capital invests in companies located in the United States with revenues of USD 2-20 million. The firm focuses on health and technology sectors such as enterprise software, technology-enabled services, digital health and healthcare services. It participates in growth transactions with an investment size of USD 5 – 15 million. The firm acquires minority interest and takes a seat on the board of directors. | Finance |
Museum of Chinese in America
Museum of Chinese in America Other Consumer ServicesConsumer Services Operates museum | Consumer Services |
Columbia Law School
 Columbia Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HiPoint Capital LP | |
Venture For America, Inc.
Venture For America, Inc. Personnel ServicesCommercial Services Provides recruitment and training services | Commercial Services |
Atlasxomics, Inc.
Atlasxomics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Allyx Therapeutics, Inc.
Allyx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops therapies to protect synapses from destruction in Alzheimer's and related neurodegenerative diseases | Commercial Services |
